IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure

Area of Science:

• Cell Biology
• Immunology
• Pharmacology

Background:

• Pro-inflammatory cytokine IL-17A affects Akt expression in bleomycin-induced lung injury.
• The precise mechanism of IL-17A's effect on Akt in alveolar basal epithelial cells is not fully understood.
• Oxidative damage is a key feature of bleomycin-induced lung injury.

Purpose of the Study:

• To investigate the IL-17A-mediated down-regulation of Akt expression in alveolar basal epithelial cells.
• To determine the role of curcumin in regulating Akt expression and mitigating oxidative damage.
• To explore the potential of curcumin as an anti-inflammatory therapeutic for lung injury.

Main Methods:

• Alveolar basal epithelial cells were treated with bleomycin (BLM) and IL-17A.
• Curcumin was administered as an intervention to counteract BLM-induced effects.
• Cell proliferation was assessed using clonogenic assays.
• Akt phosphorylation and total Akt expression were analyzed via western blot.

Main Results:

• Bleomycin treatment reduced cell proliferation, which was restored by curcumin.
• Both BLM and IL-17A significantly down-regulated Akt expression.
• Curcumin administration reversed the down-regulation of Akt expression.
• Curcumin effectively intervened in BLM and IL-17A-mediated inflammation.

Conclusions:

• IL-17A and BLM down-regulate Akt expression in alveolar basal epithelial cells.
• Curcumin acts as a regulatory molecule, reversing these effects and mitigating inflammation.
• Curcumin shows promise as an anti-inflammatory therapeutic agent for lung injury.